Inhibrx Biosciences, Inc. (INBX) vs Tyra Biosciences, Inc. (TYRA)
- Inhibrx Biosciences, Inc. INBX 89.83 −0.74%
- Tyra Biosciences, Inc. TYRA 18.52 −2.73%
Inhibrx Biosciences, Inc. and Tyra Biosciences, Inc. are both Biotechnology companies. Inhibrx Biosciences, Inc. and Tyra Biosciences, Inc. are of similar size ($1.3B and $1.3B). Across the 9 metrics below, Tyra Biosciences, Inc. leads on 5 and Inhibrx Biosciences, Inc. on 4.
Valuation
Profitability
| Metric | INBX | TYRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (1,773.60%) | (45.31%) | (56.36%) |
| Return on assets | (75.44%) | (42.15%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack